本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Denali Therapeutics Inc.

14.60
+1.4511.03%
盘后14.700.1000+0.68%16:40 EDT
成交量:186.81万
成交额:2,686.78万
市值:21.20亿
市盈率:-5.68
高:14.66
开:13.41
低:13.41
收:13.15
数据加载中...
2024/02/12

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/08

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/30

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/08

重要事件披露

Form 8-K - Current report
2024/01/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/08

重要事件披露

Form 8-K - Current report
2023/10/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/10/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/10/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities